USX:SMMT - Summit Therapeutics Inc

Summit Therapeutics PLC
Sector: Health Care, Industry: Biotechnology

Add to Watchlist

•  Default
• New Watchlist

   

Yahoo Finance

• Summary
• Financials
• Dividend
• Prices
• Posts
• User
• Alerts
• Charts

Balance Sheet Cash Flow Income Statement Key Ratios Personalized

Show %	2004 Q3	2005 Q1	2005 Q3	2006 Q1	2006 Q3	2007 Q1	2007 Q3	2008 Q1	2008 Q3	2009 Q1	2009 Q3	2010 Q1	2010 Q3	2011 Q1	2011 Q3	2012 Q1	2012 Q3	2013 Q1	2013 Q3	2014 Q1	2014 Q3	2014 Q4	2015 Q1	2015 Q2	2015 Q3	2015 Q4	2016 Q1	2016 Q2	2016 Q3	2016 Q4	2017 Q1	2017 Q2	2017 Q3	2017 Q4	2018 Q1	2018 Q2	2018 Q3	2018 Q4	2019 Q1	2019 Q2	2019 Q3	2019 Q4	2020 Q1	2020 Q3	2020 Q4	2021 Q1	2021 Q2	2021 Q3	2021 Q4	2022 Q1	2022 Q2	2022 Q3	2022 Q4	2023 Q1	2023 Q2	2023 Q3	2023 Q4	2024 Q1	Graph
Total Assets	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	128.67M -11.6%	113.37M -11.9%	116.47M 2.7%	95.72M -17.8%	155.33M 62.3%	664.17M 327.6%	254.9M -61.6%	237.37M -6.9%	218.48M -8.0%	202.95M -7.1%	176.78M -12.9%
Current Assets	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	102.21M -15.9%	97.31M -4.8%	99.44M 2.2%	79.4M -20.2%	137.12M 72.7%	656.71M 378.9%	248.03M -62.2%	227.5M -8.3%	204.95M -9.9%	189.71M -7.4%	163.26M -13.9%
Cash+Equi+Others	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	80.25M -22.4%	71.79M -10.5%	77.45M 7.9%	57.34M -26.0%	121.97M 112.7%	348.61M 185.8%	241.93M -30.6%	215.01M -11.1%	198.94M -7.5%	186.24M -6.4%	156.68M -15.9%
NonCurrent Assets	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	26.46M 10.1%	16.06M -39.3%	17.04M 6.1%	16.32M -4.2%	18.21M 11.6%	7.46M -59.1%	6.87M -7.9%	9.87M 43.7%	13.53M 37.0%	13.24M -2.1%	13.52M 2.1%
Total Liabilities	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	26.38M 1.1%	30.09M 14.1%	52.06M 73.0%	44.4M -14.7%	22.08M -50.3%	537.51M 2334.5%	121.42M -77.4%	117.77M -3.0%	119.1M 1.1%	125.26M 5.2%	132.57M 5.8%
Current Liabilities	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	22.79M 4.1%	25.62M 12.4%	22.72M -11.3%	15.17M -33.2%	16.68M 9.9%	38.78M 132.5%	17.44M -55.0%	11.93M -31.6%	113.74M 853.3%	20.41M -82.1%	23.44M 14.9%
NonCurrent Liabilities	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	3.59M -14.7%	4.47M 24.6%	29.34M 556.8%	29.23M -0.4%	5.4M -81.5%	498.73M 9140.9%	103.97M -79.2%	105.84M 1.8%	5.36M -94.9%	104.85M 1858.0%	109.13M 4.1%
Total Equity	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	102.3M -14.3%	83.28M -18.6%	64.41M -22.7%	51.32M -20.3%	133.25M 159.7%	126.65M -4.9%	133.48M 5.4%	119.6M -10.4%	99.38M -16.9%	77.69M -21.8%	44.21M -43.1%
Stockholders Equity	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	102.3M -14.3%	83.28M -18.6%	64.41M -22.7%	51.32M -20.3%	133.25M 159.7%	126.65M -4.9%	133.48M 5.4%	119.6M -10.4%	99.38M -16.9%	77.69M -21.8%	44.21M -43.1%
Minority Interest	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	-	-	-	-	-	-	-	-	-	-	-